Navigation Links
Advanced imaging technology used at Mayo Clinic improves spinal surgery outcome
Date:12/10/2008

JACKSONVILLE, Fla. Using a three-dimensional (3D) image-guided system to help place screws in the spines of patients results in safe and accurate surgery with a decrease in the number of misplaced screws, and subsequent injuries, seen in more traditional operations, say neurosurgeons at Mayo Clinic in Florida.

In the Dec. 9 online edition of the Journal of Neurosurgery: Spine, Mayo physicians published the largest study yet using 3D image-guided technology to place screws in the spine for spinal fusion procedures. The screws are used to stabilize the spine in patients who suffer from collapsed discs or compressed nerves.

Specifically, after implanting 1084 "pedicle" screws in 220 patients, surgeons reported a nerve injury rate of less than 1 percent. Additionally, less than 1 percent of the screws in this study were considered to be significantly misplaced. That compares to a reported nerve injury rate of up to 8 percent and a misplacement rate of up to 55 percent using standard technology. As well, re-operation for removal of a misplaced screw has been reported in other surgical literature to be as high as 6.5 percent but occurred in less than half of one percent of all patients in the Mayo study, according to the researchers.

"Using 3D image-guided technology to help us place these screws results in a much better outcome for our patients," says Mayo Clinic neurosurgeon Eric Nottmeier, M.D., the study's lead investigator. "In addition to the decreased incidence of nerve root injury, this technology allows us to place larger screws into the spine, which can also increase the success rate of the operation."

The technology uses a special camera on a computer that uses infrared light to track a surgical instrument in 3D space. The surgeon places the instrument on the patient's spine and navigates the spine using the computer. The surgical instrument is used to determine the best entry point and trajectory for each scre
'/>"/>

Contact: Cynthia Nelson
nelson.cynthia1@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
2. International study supports new standard of treatment for women with advanced ovarian cancer
3. Preoperative radiation may improve survival rates in advanced rectal cancer patients
4. Dr. Paul M. Parker Is Pioneering New Advanced Lipoabdominoplasty Instead of Traditional Tummy Tuck in New Jersey
5. New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
6. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
7. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
8. Advanced lung cancer patients see improved, progression-free survival
9. Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures
10. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
11. Philips Introduces New, Advanced Light Therapy Device to Offer Quick Relief from Winter Blues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Chicago have discovered a technique that is able to ... or habitual snoring by screening their urine. , ... relatively simple urine test that could detect OSA in ... and inconvenient sleep studies in children who snore, only ... OSA," said lead author David Gozal, M.D., professor and ...
(Date:12/6/2009)... and SUNNYVALE, Calif., Dec. 6 Pharmacyclics, ... results from a Phase I/II study showing safety ... recurrent non-Hodgkin,s Lymphoma (NHL) treated with its HDAC ... were presented today at the 51st ASH Annual ... # 2726). ,, PCI-24781 is an oral ...
(Date:12/6/2009)... Scientists in Cambridge have discovered that the loss of a ... This is the first study to show that this kind ... today in Nature . , The study, led by ... Matt Hurles from the Wellcome Trust Sanger Institute, looked at ... child,s entire genome looking for types of mutation known as ...
(Date:12/6/2009)... researchers from the Medical College of Wisconsin, in Milwaukee, ... and other sickle cell disease complications in children. Barriers ... and patients were also identified. The study led ... pediatrics at the Medical College and Children,s Research Institute ... at the American Society of Hematology meeting Dec. 7, ...
(Date:12/6/2009)... -- Blood clotting, or coagulation, is an important ... vessel is injured. Sometimes, however, clots form on ... or do not dissolve naturally, a potentially life-threatening ... 51st Annual Meeting of the American Society of ... anticoagulants aspirin and heparin with the hope of ...
Breaking Medicine News(10 mins):Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7
... Crdentia Corp. (OTC Bulletin,Board: CRDT), a leading healthcare ... Jones to Vice President of Operations of Crdentia,s,newly ... immediately. Mr. Jones joins Crdentia from ATS ... allied health staffing services with six offices in,Florida, ...
... -- China Technology,Development Group Corporation (Nasdaq: CTDC; ... energy solutions and network security focusing in ... the appointment of Dr.,Jerry Yan as Chief ... development of the,Company,s strategy, establish an expert ...
... Analysis shows Vermont, Minnesota and Hawaii are nation,s ... Louisiana rank as least-healthy states, WASHINGTON, Nov. ... over the past year, despite progress made in ... today by United Health,Foundation, the American Public Health ...
... Increase Nearly 17 Percent; Ambulatory Surgical ... Centers Increase 364 ... ENDO ), an innovative medical device company focused on the,development ... tissue and tumor ablation, announced today,that the federal Centers for ...
... SAN DIEGO, Nov. 5 ADVENTRX Pharmaceuticals,Inc. (Amex: ... company,focused on commercializing proprietary product candidates for the ... Brian M. Culley,ADVENTRX,s chief business officer, is scheduled ... on November 14th, 2007 at 11:30,a.m. Central European ...
... HAVEN, Conn., Nov. 5 ,Following consultation with the ... the U.S. Food and Drug Administration (FDA),Health Canada, ... it,has elected to temporarily suspend worldwide marketing of ... BART trial can,be compiled, received and evaluated. The ...
Other Medicine News:Health News:Crdentia Announces Appointment of Tim Jones to Senior Management Team 2Health News:Crdentia Announces Appointment of Tim Jones to Senior Management Team 3Health News:CTDC Appoints Chief Scientist 2Health News:CTDC Appoints Chief Scientist 3Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 2Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 3Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 4Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 5Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 6Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 7Health News:Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer 2Health News:Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer 3Health News:ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference 2Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 2Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 3Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 4
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... Ill., Dec. 4 Hospira, Inc. (NYSE: ... delivery company, today announced the launch of its next-generation ... (I.V.) medications and solutions, and now offers a complete ... award-winning, environmentally responsible VisIV product. The launch of the ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2More Ontario children are getting diagnosed with diabetes 3A ICES study 48205 1Common chemotherapy drug triggers fatal allergic reactions 8748 1Common chemotherapy drug triggers fatal allergic reactions 8748 2Common chemotherapy drug triggers fatal allergic reactions 8748 3
... NEW YORK, June 30 In the fall of ... receive music from artists they,love and artists they will discover ... model will create a new revenue stream for artists,and labels ... Don MacKinnon, founder of HEAR Music and former Vice ...
... Increase in Mature Dendritic Cells -, WAYNE, ... that results of a Phase II trial were,published ... of Clinical Oncology. The,study showed that Leukine(R) (sargramostim) ... increased mature dendritic cells in high-risk,melanoma patients. Dendritic ...
Other Medicine Technology:(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 2(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa 3Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 2Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 3Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 4Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 5
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca...
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Manual Table For Slit Lamp...
Medicine Products: